WHO suggestions require manufacturers to carry out a constant risk management process for sterility test isolators, which include normal risk assessments and the event of risk-based control techniques. Manufacturers aiming to put into action these strategies have to offer strong validation data to demonstrate their equivalence to pharmacopoeial solutions. https://matters.town/a/99kdxeeq6mva